世界最大級の体外診断薬系展示会「ADLM 2025」にライフサイエンス製品群Sciforiem®（サイフォリーム）シリーズを出展

July 9, 2025, Tokyo, Japan—artience Co., Ltd., the holding company for Tokyo-based chemicals manufacturing group, artience Group, will be rolling out the Sciforiem™ PL 1000 Series of functional synthetic polymers to markets outside of Japan, beginning July. Sciforiem polymers are synthesized from non-biological raw materials and can be engineered to replicate biological functions, making them valuable for the development of biosensors, diagnostic assays and other in vitro diagnostic (IVD) systems.

IVDs are medical devices used to analyze biological samples like blood or tissue to diagnose diseases. Sciforiem PL 1000 polymers are specially optimized for use in IVDs that rely on antigen-antibody reactions to detect target molecules. When used to coat the substrate material in antigen-antibody reaction detection, these polymers can prevent non-specific protein adsorption, enhance detection sensitivity and stabilize proteins, thus improving overall reagent performance.

Such biological functions performed by Sciforiem polymers are useful in various applications, such as blocking agents in immunoassays like ELISA and immunochromatography or as protein stabilizers in IVD assays. In biomolecule research, they act as additives in diagnostic reagents due to their ability to enhance functionality and stability.

With a century-plus heritage rooted in printing ink innovation, artience is uniquely positioned to apply its cutting-edge technologies, which have been honed over the decades, to engineer polymer products that address the stringent quality standards of today’s medical, electronics and other high-end fields. “Historically, bio raw materials were considered a biomanufacturing challenge for their inconsistent quality,” said Nozomu Hatano, General Manager of artience's Biotech Business Unit in Japan. “By adopting artience’s polymer design and dispersion technologies to address stability issues in raw materials, our engineers were able to fabricate a functional polymer for in vitro diagnostic reagents that exhibit minimal variation in quality. We expect the new Sciforiem PL 1000 Series to significantly reduce diagnostic errors and improve patient care, going forward.”

The Sciforiem Series of life science products from artience will be making its global debut at ADLM 2025 (or ADLM Annual Scientific Meeting & Clinical Lab Expo), in Chicago, from July 27 to 31, 2025. In addition to functional synthetic polymers, artience will be featuring the Sciforiem FI Series of near-infrared (NIR) fluorescence probes for high-sensitivity imaging.

For more information on artience Bioscience Solutions, see
https://www.artiencegroup.com/en/products/solution/bioscience/index.html

For more information on ADLM 2025, see the official website
https://meeting.myadlm.org/

About artience

Founded in 1896, artience Co., Ltd. (TSE 4634; formerly Toyo Ink SC Holdings), the Japan-based parent company of the artience group, has long been providing innovative solutions that meet the needs of society by applying our core technologies of coatings, dispersions, polymer design, color materials design, and analysis and materials informatics. Today, artience is a diversified chemicals manufacturing group that delivers fine chemical products to a broad range of global industrial markets. With a network of roughly 8,000 employees in over 20 countries, we are continually working to solve the challenges that faces society, with the ultimate aim of building a future where all people can live enriched lives. For more information on artience, visit https://www.artiencegroup.com/en/.